Variation in harms and benefits of prostate-specific antigen screening for prostate cancer by socio-clinical risk factors: A rapid review.
Tesfai Abel, Norori Natalia, Harding Thomas A, +2 more·BJUI compass
OBJECTIVE: To analyse the latest evidence on the relative harms and benefits of screening and diagnostic pathways with close examination of (i) men aged 50 years or older, (ii) men whose ethnicity places them at higher risk and (iii) men with a family history. METHODS: We conducted a literature search using Pub…